Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
67 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-INDAPAMIDE 2.5MG TABLETS | 2.5MG | TABLET | Resolved | 2023-08-04 | 2023-08-18 | 201168 |
| APO-IPRAVENT STERULES | 0.025% | SOLUTION | Actual shortage | 2017-08-13 | 2017-10-05 | 19060 |
| APO-IPRAVENT STERULES | 125MCG | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19111 |
| APO-IRBESARTAN | 150MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 336 |
| APO-IRBESARTAN | 300MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 339 |
| APO-IRBESARTAN | 75MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 342 |
| APO-IRBESARTAN | 300MG | TABLET | Resolved | 2018-05-15 | 2018-09-11 | 49408 |
| APO-IRBESARTAN | 150MG | TABLET | Avoided shortage | 2018-07-15 | 2018-08-21 | 55788 |
| APO-IRBESARTAN | 75MG | TABLET | Avoided shortage | 2018-07-15 | 2018-08-21 | 55791 |
| APO-IRBESARTAN | 300MG | TABLET | Avoided shortage | 2018-07-15 | 2018-08-21 | 55810 |
| APO-IRBESARTAN | 75MG | TABLET | Actual shortage | 2018-11-09 | 2018-11-09 | 66534 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-03-10 | 2017-04-24 | 345 |
| APO-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-03-10 | 2017-04-24 | 351 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2017-10-11 | 2017-11-15 | 25287 |
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-05-22 | 2018-08-09 | 50044 |
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-25 | 2018-02-23 | 16871 |
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-25 | 2017-09-25 | 16874 |
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-06-06 | 2025-05-01 | 229755 |
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-04-10 | 354 |
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-02 | 2017-06-27 | 8602 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |